Combining anti-IgM and IgG immunoassays for comprehensive chikungunya virus diagnostic testing
- PMID: 31449360
- DOI: 10.1111/zph.12641
Combining anti-IgM and IgG immunoassays for comprehensive chikungunya virus diagnostic testing
Abstract
Chikungunya virus (CHIKV) is a mosquito-borne pathogen that causes CHIKV fever. Definitive diagnosis is crucial for patients experiencing symptoms similar to other arboviral diseases because they can vary in clinical consequences. An increasing number of patients experience long-term rheumatic effects of CHIKV infection, but these cases may not be optimally detected by molecular assays and anti-CHIKV IgM ELISAs (M-ELISAs) used for confirmation and screening, respectively. The subsequent confirmatory serological test, the plaque reduction neutralization test (PRNT), is laborious and time-consuming. In this study, we evaluated a new diagnostic algorithm in which the M-ELISA is conducted in parallel with an anti-CHIKV IgG ELISA (G-ELISA) and observed that the Euroimmun M-ELISA combined with the Euroimmun G-ELISA or the Abcam G-ELISA exhibited excellent sensitivity and specificity for CHIKV. The combinations demonstrated perfect and near perfect inter-rater agreement with the PRNT, respectively, suggesting their potential to be used as alternatives to the confirmatory serological PRNT assay for CHIKV.
Keywords: chikungunya virus; diagnostic testing; serology.
© 2019 Blackwell Verlag GmbH.
Similar articles
-
Diagnostic accuracy of serological tests for the diagnosis of Chikungunya virus infection: A systematic review and meta-analysis.PLoS Negl Trop Dis. 2022 Feb 4;16(2):e0010152. doi: 10.1371/journal.pntd.0010152. eCollection 2022 Feb. PLoS Negl Trop Dis. 2022. PMID: 35120141 Free PMC article.
-
Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.Clin Vaccine Immunol. 2016 Oct 4;23(10):825-830. doi: 10.1128/CVI.00330-16. Print 2016 Oct. Clin Vaccine Immunol. 2016. PMID: 27535838 Free PMC article.
-
Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays.Am J Trop Med Hyg. 2016 Jul 6;95(1):182-192. doi: 10.4269/ajtmh.16-0013. Epub 2016 Mar 14. Am J Trop Med Hyg. 2016. PMID: 26976887 Free PMC article.
-
Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.mSphere. 2020 Feb 5;5(1):e00915-19. doi: 10.1128/mSphere.00915-19. mSphere. 2020. PMID: 32024703 Free PMC article.
-
Luciferase Immunosorbent Assay Based on Multiple E Antigens for the Detection of Chikungunya Virus-Specific IgG Antibodies.Microbiol Spectr. 2022 Apr 27;10(2):e0149621. doi: 10.1128/spectrum.01496-21. Epub 2022 Mar 21. Microbiol Spectr. 2022. PMID: 35311573 Free PMC article. Review.
Cited by
-
Development of Nucleic Acid Lateral Flow Immunoassay for Rapid and Accurate Detection of Chikungunya Virus in Indonesia.J Microbiol Biotechnol. 2021 Dec 28;31(12):1716-1721. doi: 10.4014/jmb.2108.08025. J Microbiol Biotechnol. 2021. PMID: 34584033 Free PMC article.
-
Diagnostic accuracy of serological tests for the diagnosis of Chikungunya virus infection: A systematic review and meta-analysis.PLoS Negl Trop Dis. 2022 Feb 4;16(2):e0010152. doi: 10.1371/journal.pntd.0010152. eCollection 2022 Feb. PLoS Negl Trop Dis. 2022. PMID: 35120141 Free PMC article.
-
A Chikungunya Virus Multiepitope Recombinant Protein Expressed from the Binary System Insect Cell/Recombinant Baculovirus Is Useful for Laboratorial Diagnosis of Chikungunya.Microorganisms. 2022 Jul 18;10(7):1451. doi: 10.3390/microorganisms10071451. Microorganisms. 2022. PMID: 35889170 Free PMC article.
-
Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells-Comparison of Their Performances in ELISA.Viruses. 2020 Aug 26;12(9):939. doi: 10.3390/v12090939. Viruses. 2020. PMID: 32858804 Free PMC article.
-
Large-scale outbreak of Chikungunya virus infection in Thailand, 2018-2019.PLoS One. 2021 Mar 10;16(3):e0247314. doi: 10.1371/journal.pone.0247314. eCollection 2021. PLoS One. 2021. PMID: 33690657 Free PMC article.
References
REFERENCES
-
- Alfaro-Toloza, P., Clouet-Huerta, D. E., & Rodríguez-Morales, A. J. (2015). Chikungunya, the emerging migratory rheumatism. The Lancet Infectious Diseases, 15(5), 510-512. https://doi.org/10.1016/S1473-3099(15)70160-X
-
- Auguste, A. J., Liria, J., Forrester, N. L., Giambalvo, D., Moncada, M., Long, K. C., … Weaver, S. C. (2015). Evolutionary and ecological characterization of mayaro virus strains isolated during an outbreak, Venezuela, 2010. Emerging Infectious Diseases, 21(10), 1742-1750. https://doi.org/10.3201/eid2110.141660
-
- Borgherini, G., Poubeau, P., Staikowsky, F., Lory, M., Le Moullec, N., Becquart, J. P., … Paganin, F. (2007). Outbreak of chikungunya on Reunion Island: Early clinical and laboratory features in 157 adult patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 44(11), 1401-1407. https://doi.org/10.1086/517537
-
- Chang, A. Y., Encinales, L., Porras, A., Pacheco, N., Reid, S. P., Martins, K. A. O., … Simon, G. L. (2018). Frequency of chronic joint pain following chikungunya virus infection. Arthritis & Rheumatology, 70(4), 578-584. https://doi.org/10.1002/art.40384
-
- Chang, A. Y., Martins, K. A. O., Encinales, L., Reid, S. P., Acuña, M., Encinales, C., … Firestein, G. S. (2018). Chikungunya arthritis mechanisms in the Americas. Arthritis & Rheumatology, 70(4), 585-593. https://doi.org/10.1002/art.40383
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical